Drug intelligence / Profile preview

DC161-DP0292

Development stage
Unknown
Lead developer
Pierre Fabre
Administration
Oral (spray)
01

Overview

DC161-DP0292 is an **aqueous oral spray saliva substitute** developed as a treatment for **drug-induced xerostomia** (dry mouth) in adults with hyposalivation. Its mechanism is based on **mechanical and physicochemical lubrication** of the oral mucosa, acting as an artificial saliva to relieve symptoms such as mouth dryness, difficulty swallowing, and speaking. The formulation includes **glycerol, povidone K30, xanthan gum, potassium chloride, xylitol, potassium dihydrogen phosphate, benzylic alcohol, water, and macroglycerol 40 hydroxystearate**. Clinical studies show it provides **fast and long-acting symptomatic relief** and is well-tolerated, with high acceptability for taste, texture, and lubricating effect compared to comparator sprays. It does not act via a pharmacological receptor or enzyme, but recreates the physical actions of saliva, making it a symptomatic, not disease-modifying, therapy[1][2][3][5][6].

Brand names
Elgydium Clinic Dry Mouth
Other names
DC161-DP0292DC-161-DP0292DC 161-DP0292DC161 oral spray (when referring to specific formulation)

Beyond the preview

Go deeper on DC161-DP0292.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DC161-DP0292.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call